IDO1 and type 1 diabetes mellitus: It has to be noted that the mechanisms of IDO1 actions could be different in an autoimmune context such as type I diabetes, where the observed low level of IDO1 may weaken the immunomodulatory microenvironment, and make the pancreatic β-cells more susceptible to inflammatory deleterious response (30).